Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-13

Clinical Trial Update: Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing Dolutegravir and Associated Nucleoside / Nucleotide Reverse Transcriptase Inhibitors Backbone [NA]

View source ↗

Summary

Clinical trial NCT04133012 studied the relationship between virologic reservoirs and antiretroviral concentrations in HIV-1 chronic patients on a first-line dol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tivicay (dolutegravir) (dolutegravir)

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: HIV-1 Infection | NA | Status: COMPLETED